Background: A malignant bone tumour is a neoplastic growth of tissue in bone which can be benign or malignant. Amputation is the removal part or all of a limb. When used to treat cancer, amputation removes the limb part with the tumour, some healthy tissue above it, and everything below it. The prognosis depends on the type of tumour. The outcome is expected to be good for people with benign tumours, although some types of benign tumours may eventually become malignant.Methods: Observational descriptive cross-sectional hospital-based study was conducted in Ibrahim Malik Teaching Hospital in Khartoum State in the period from January 2018 to September 2018. Data was collected using a datasheet. Data entered and analyzed using SPSS version 25.0. Results:This study covered 50 study participants, most of them (96%) were less than 40 years of age. Our study found that only (16%) of the study participants were fully aware of their disease while (40%) were not aware at all. Furthermore, there was a delay between the presentation and starting the treatment among most of them (90%) while (82%) had tried other traditional or non-formal methods of treatment. Concerning the type of tumour, most of the study participants (84%) were diagnosed with osteosarcoma, while a small proportion of them was diagnosed with Chondrosarcoma (6%), Ewing sarcoma (6%), and Admantinoma among only (4%). The study found that the total number of patients with primary bone sarcoma were 65 patient from January to June 2018(hospital records) so the incidence of amputation at that time was 76%. Regarding the management applied, all study participants were amputated, of which (56%) had chemotherapy and (12%) had radiotherapy. The analysis found that there is a significant association between the level of education and the delayed presentation (pvalue < 0/001). Conclusion:A high awareness of malignant bone tumours are essential to avoid diagnostic delays. Some might even be dangerous.
Background: A malignant bone tumour is a neoplastic growth of tissue in bone which can be benign or malignant. Amputation is the removal part or all of a limb. When used to treat cancer, amputation removes the limb part with the tumour, some healthy tissue above it, and everything below it. The prognosis depends on the type of tumour. The outcome is expected to be good for people with benign tumours, although some types of benign tumours may eventually become malignant.Methods: Observational descriptive cross-sectional hospital-based study was conducted in Ibrahim Malik Teaching Hospital in Khartoum State in the period from January 2018 to September 2018. Data was collected using a datasheet. Data entered and analyzed using SPSS version 25.0. Results:This study covered 50 study participants, most of them (96%) were less than 40 years of age. Our study found that only (16%) of the study participants were fully aware of their disease while (40%) were not aware at all. Furthermore, there was a delay between the presentation and starting the treatment among most of them (90%) while (82%) had tried other traditional or non-formal methods of treatment. Concerning the type of tumour, most of the study participants (84%) were diagnosed with osteosarcoma, while a small proportion of them was diagnosed with Chondrosarcoma (6%), Ewing sarcoma (6%), and Admantinoma among only (4%). The study found that the total number of patients with primary bone sarcoma were 65 patient from January to June 2018(hospital records) so the incidence of amputation at that time was 76%. Regarding the management applied, all study participants were amputated, of which (56%) had chemotherapy and (12%) had radiotherapy. The analysis found that there is a significant association between the level of education and the delayed presentation (pvalue < 0/001). Conclusion:A high awareness of malignant bone tumours are essential to avoid diagnostic delays. Some might even be dangerous.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.